Double coronary thrombosis in a patient with Behçet's disease

Luís Abreu1, Bruno Marmelo1, Júlio Gil1

  • 1Serviço Cardiologia, Centro Hospitalar Tondela Viseu, Viseu, Portugal.

Insights

This case study highlights a rare cardiac complication of Behçet's disease (BD). A patient with BD experienced ST-elevation myocardial infarction (STEMI) and underwent successful percutaneous coronary intervention.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Behçet's disease is a rare multisystem autoinflammatory disorder.
  • Cardiac involvement in Behçet's disease, though uncommon, presents significant life-threatening risks.
  • Current treatments focus on empirical immunosuppression to manage vasculitis.

Observation:

  • A 42-year-old male with a history of Behçet's disease presented with ST-elevation myocardial infarction (STEMI).
  • The patient exhibited combined thrombosis in the left anterior descending and right coronary arteries.
  • He required two percutaneous coronary interventions with drug-eluting stent implantation due to a high thrombotic burden.

Findings:

  • The patient's clinical course during hospitalization was favorable, with no evidence of systolic dysfunction upon discharge.
  • Follow-up assessments indicated no new cardiovascular events, suggesting successful management of the acute event.

Implications:

  • This case underscores the importance of considering cardiac complications in Behçet's disease patients presenting with ischemic symptoms.
  • Aggressive interventional management, including percutaneous coronary intervention, can be effective in treating acute coronary syndromes in this population.
  • Further research into the specific mechanisms of cardiac involvement in Behçet's disease is warranted to optimize treatment strategies.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
164
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
226
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
306
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
261
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
247
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
196